ConductScience.org, home

Trial · NCT01003015

Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma

NCT01003015, Phase 2, Completed, Bayer

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma. Trials, record NCT01003015. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01003015

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma
NCT number
NCT01003015
Status
Completed
Phases
Phase 2
Enrollment
36 participants, actual
Lead sponsor
Bayer
Conditions
Carcinoma, Hepatocellular
Interventions
BAY73-4506
First posted
2009-10-28
Last updated
2015-04-03
Other registries' IDs
eudract:2009-012570-13

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAdverse Event CollectionUp to 30+/- 7 days after permanently discontinuing BAY73-4506 administration
SecondaryTime to progressionEvery 6 weeks during treatment and after 6 cycle treatment every 18 weeks till progression
SecondaryObjective response rateEvery 6 weeks during treatmen and after 6 cycle treatment every 18 weeks till progression
SecondaryDisease control rateEvery 6 weeks during treatmen and after 6 cycle treatment every 18 weeks till progression
SecondaryOverall survivalEvery 6 weeks during treatmen and after 6 cycle treatment every 18 weeks till progression
SecondaryTrough concentration of Regorafenib and metabolites (for Europe only)Cycle 1 Day 15 and Cycle 2 Day 1
SecondaryFull Pharmacokinetics profile of BAY73-4506 and metabolites (for Korea only)Cycle 1 Day 21 to Day 28

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
23809766RESULT

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01003015

GET https://conductscience.org/api/trials/v1/NCT01003015/registered